[go: up one dir, main page]

CL2013003713A1 - Metodo para determinar el contenido de sialilación de una proteína que comprende preparar proteina para análisis y tratar enzimáticamente dicha proteína; uso de cromatografía hpaec-pad para determinar el contenido de sialilación de una proteína; kit para determinar el contenido de sialilación. - Google Patents

Metodo para determinar el contenido de sialilación de una proteína que comprende preparar proteina para análisis y tratar enzimáticamente dicha proteína; uso de cromatografía hpaec-pad para determinar el contenido de sialilación de una proteína; kit para determinar el contenido de sialilación.

Info

Publication number
CL2013003713A1
CL2013003713A1 CL2013003713A CL2013003713A CL2013003713A1 CL 2013003713 A1 CL2013003713 A1 CL 2013003713A1 CL 2013003713 A CL2013003713 A CL 2013003713A CL 2013003713 A CL2013003713 A CL 2013003713A CL 2013003713 A1 CL2013003713 A1 CL 2013003713A1
Authority
CL
Chile
Prior art keywords
protein
sialylation
content
hpaec
kit
Prior art date
Application number
CL2013003713A
Other languages
English (en)
Inventor
Zihao Wang
Jessica Sloan
Kevin Wee
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of CL2013003713A1 publication Critical patent/CL2013003713A1/es

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • G01N2333/938Hydrolases (3) acting on glycosyl compounds (3.2) acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CL2013003713A 2011-07-14 2013-12-24 Metodo para determinar el contenido de sialilación de una proteína que comprende preparar proteina para análisis y tratar enzimáticamente dicha proteína; uso de cromatografía hpaec-pad para determinar el contenido de sialilación de una proteína; kit para determinar el contenido de sialilación. CL2013003713A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161507643P 2011-07-14 2011-07-14

Publications (1)

Publication Number Publication Date
CL2013003713A1 true CL2013003713A1 (es) 2014-08-08

Family

ID=47557705

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003713A CL2013003713A1 (es) 2011-07-14 2013-12-24 Metodo para determinar el contenido de sialilación de una proteína que comprende preparar proteina para análisis y tratar enzimáticamente dicha proteína; uso de cromatografía hpaec-pad para determinar el contenido de sialilación de una proteína; kit para determinar el contenido de sialilación.

Country Status (22)

Country Link
US (1) US9260743B2 (es)
EP (1) EP2733218B1 (es)
JP (1) JP2014525742A (es)
KR (1) KR101864468B1 (es)
CN (1) CN103635590A (es)
AR (1) AR087175A1 (es)
AU (1) AU2012285696B2 (es)
BR (1) BR112013033883B1 (es)
CA (1) CA2837981C (es)
CL (1) CL2013003713A1 (es)
ES (1) ES2675511T3 (es)
HU (1) HUE038020T2 (es)
IL (1) IL229828A (es)
MX (1) MX344407B (es)
MY (1) MY163078A (es)
PL (1) PL2733218T3 (es)
PT (1) PT2733218T (es)
RU (1) RU2605900C2 (es)
SG (1) SG10201500002XA (es)
TR (1) TR201809082T4 (es)
UY (1) UY34195A (es)
WO (1) WO2013011178A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9260743B2 (en) * 2011-07-14 2016-02-16 Grifols. S.A. Rapid and accurate analysis of protein sialylation
CN106324234B (zh) * 2016-08-08 2018-05-22 上海睿康生物科技有限公司 修饰的n-乙酰神经氨酸醛缩酶及其制备方法和应用
CN107045019B (zh) * 2016-09-30 2019-08-16 中国医学科学院输血研究所 一种IVIG中IgG Fab片段和Fc片段唾液酸含量的测定方法
CN110346500B (zh) * 2018-04-04 2021-11-30 青岛大学附属医院 一种基于微波酸水解的阴离子交换色谱-脉冲安培法检测血清中单糖含量的检测方法
CN109329713B (zh) * 2018-12-01 2022-04-22 西华大学 一种降解牦牛肉中n-羟乙酰神经唾液酸的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5570677B2 (ja) * 2002-04-25 2014-08-13 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド α−ガラクトシダーゼA欠損症の治療
EP1400533A1 (en) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH HASylated polypeptides, especially HASylated erythropoietin
US8039208B2 (en) 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
DE602005017519D1 (de) * 2005-04-26 2009-12-17 Nat Inst For Bioproc Res And T Automatische glykofingerabdruck-strategie
CA2720610C (en) * 2008-04-07 2016-08-23 Bayer Healthcare Llc Methods of recombinant production of glycoproteins
US20110086362A1 (en) * 2009-10-09 2011-04-14 Massachusetts Institute Of Technology High-Throughput Method for Quantifying Sialylation of Glycoproteins
US9260743B2 (en) * 2011-07-14 2016-02-16 Grifols. S.A. Rapid and accurate analysis of protein sialylation

Also Published As

Publication number Publication date
MY163078A (en) 2017-08-15
WO2013011178A1 (es) 2013-01-24
EP2733218A1 (en) 2014-05-21
JP2014525742A (ja) 2014-10-02
AR087175A1 (es) 2014-02-26
PT2733218T (pt) 2018-07-04
CA2837981C (en) 2020-08-18
CA2837981A1 (en) 2013-01-24
RU2605900C2 (ru) 2016-12-27
SG10201500002XA (en) 2015-02-27
AU2012285696B2 (en) 2015-12-10
MX344407B (es) 2016-12-14
CN103635590A (zh) 2014-03-12
EP2733218B1 (en) 2018-05-30
US20140162299A1 (en) 2014-06-12
KR20140060289A (ko) 2014-05-19
BR112013033883A2 (pt) 2017-02-14
BR112013033883B1 (pt) 2020-11-03
ES2675511T3 (es) 2018-07-11
EP2733218A4 (en) 2015-03-25
KR101864468B1 (ko) 2018-06-04
PL2733218T3 (pl) 2018-08-31
AU2012285696A1 (en) 2013-05-09
IL229828A (en) 2016-09-29
RU2013154278A (ru) 2015-06-20
NZ618889A (en) 2015-08-28
US9260743B2 (en) 2016-02-16
MX2014000378A (es) 2014-03-31
TR201809082T4 (tr) 2018-07-23
UY34195A (es) 2013-02-28
HUE038020T2 (hu) 2018-09-28

Similar Documents

Publication Publication Date Title
CY2017021I2 (el) Υψηλης συναφειας ανθρωπινα αντισωματα προς pcsk9
BR112013024574A2 (pt) polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo
CL2013003792A1 (es) Metodo para detener el crecimiento celular en un cultivo celular de mamíferos que expresan una proteina recombinante.
BR112014018136A2 (pt) anticorpos ou uso e método para determinar
SMT201600398B (it) Inibitori di proteina chinasi (varianti), uso di questi nel trattamento di malattie oncologiche e composizione farmaceutica basata su questi
HRP20170138T1 (hr) Ponovno dobivanje proteina
BR112013018877A2 (pt) composições farmacêuticas que compreendem anticorpos humanos para pcsk9
DK3257564T4 (da) Overstrøms- og elutionskromatografi
BR112017011932A2 (pt) ?anticorpos direcionados a receptor acoplado a proteína g e métodos de uso?
CO6970559A2 (es) Dominios no inmunizados que se unen al suero y su uso para extender la vida media en el suero
BRPI0921320A2 (pt) composições de anticorpo estáveis e métodos para estabilizar os mesmos
EP2663857A4 (en) METHOD OF DETECTION OF PROTEINS
BRPI0917564A2 (pt) bioensaio para proteína poli-q
BR112014029107A2 (pt) método para determinar a concentração de uma espécie de polissorbato em uma mistura.
EP2961762A4 (en) CHROMATOGRAPHIC MEMBRANES WITH MIXING MODE OPERATION
HRP20190210T1 (hr) Enterički premazani multipartikulatni pripravak s proteinskim podslojem
PT2594588E (pt) Anticorpo anti-adrenomedulina (adm) ou fragmento de anticorpo anti-adm ou andaime proteico não ig anti-adm para utilização em terapia
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
BR112014002716A2 (pt) anticorpos anti-poliubiquitina e métodos de uso
BR112014008088A2 (pt) método para detectar anticorpos, uso de um método, e, kit
BR112012016229A2 (pt) método para melhorar a sobrevida livre de progressão, método in vitro, kit, uso de um oligonucleotídeo ou polipetídeo e uso de bevacizumab
MX2019009539A (es) Aminoesteroides para tratamiento de una enfermedad asociada con proteina fosfatasa 1b ( ptp1b).
BRPI0909885A2 (pt) composição decorativa e método para sua utilização
BR112016010822A2 (pt) anticorpos específicos para fcrn
BR112013022883A2 (pt) aptâmero, composição farmacêutica, kit, uso de um aptâmero e coluna de aférese